Teleflex | TFX - Operating Expenses

Stock Price
136.56
Daily Change
-0.09 -0.07%
Monthly
26.23%
Yearly
0.99%
Q2 Forecast
133.64

Teleflex reported $532.64M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Align Technology USD 822.85M 11.8M Dec/2025
AngioDynamics USD 81.95M 1.68M Sep/2025
AtriCure USD 138.01M 3.95M Dec/2025
Avanos Medical USD 156.13M 2.7M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
Cooper Companies USD 811.3M 113.5M Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
General Electric Aerospace USD 18.06B 7.11B Mar/2026
Globus Medical USD 645.11M 241.46M Dec/2025
Haemonetics USD 134.99M 1.26M Dec/2025
Inogen USD 49.14M 665K Sep/2024
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
Intuitive Surgical USD 1.91B 89.8M Mar/2026
J&J USD 17.44B 1.53B Mar/2026
Masimo USD 328.6M 181.6M Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Merit Medical Systems USD 339.74M 1.8M Dec/2025
Orthofix International USD 213.79M 12.36M Dec/2025
ResMed USD 925.21M 51.98M Dec/2025
Steris USD 1.22B 28.8M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025